Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Drug Administration Schedule"" wg kryterium: Temat


Tytuł :
A randomized clinical trial comparing physician-directed or fixed-dose steroid replacement strategies for incomplete dexamethasone dosing prior to docetaxel chemotherapy.
Autorzy :
Hsu T; Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, Canada.; Department of Medicine, The University of Ottawa, Ottawa, Canada.
Fergusson D; Department of Medicine, The University of Ottawa, Ottawa, Canada.; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Stober C; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Daigle K; Department of Nursing, The Ottawa Hospital and the Ottawa Hospital Cancer Centre, Ottawa, Canada.
Moledina N; Department of Nursing, The Ottawa Hospital and the Ottawa Hospital Cancer Centre, Ottawa, Canada.
Vandermeer L; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Pond G; Department of Oncology, McMaster University, Hamilton, Canada.
Hilton J; Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, Canada.; Department of Medicine, The University of Ottawa, Ottawa, Canada.
Hutton B; Department of Medicine, The University of Ottawa, Ottawa, Canada.; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Clemons M; Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, Canada. .; Department of Medicine, The University of Ottawa, Ottawa, Canada. .; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada. .; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, Canada. .
Pokaż więcej
Corporate Authors :
REaCT investigators
Źródło :
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2021 Jun; Vol. 29 (6), pp. 3113-3120. Date of Electronic Publication: 2020 Oct 15.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Drug Administration Schedule*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Dexamethasone/*therapeutic use
Docetaxel/*therapeutic use
Glucocorticoids/*therapeutic use
Premedication/*methods
Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Dexamethasone/pharmacology ; Docetaxel/pharmacology ; Female ; Glucocorticoids/pharmacology ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study.
Autorzy :
Suehs CM; Département des Maladies Respiratoires and.
Menzies-Gow A; PhyMedExp, Université de Montpellier, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Centre Hospitalier Universitaire Montpellier, Montpellier, France.
Price D; Royal Brompton and Harefield National Health Service Foundation Trust, London, United Kingdom.; Observational and Pragmatic Research Institute, Singapore.
Bleecker ER; Division of Applied Health Sciences, Centre of Academic Primary Care, University of Aberdeen, Aberdeen, United Kingdom.
Canonica GW; Department of Medicine, University of Arizona, Tucson, Arizona.
Gurnell M; Personalized Medicine, Asthma and Allergy Center, Humanitas University and IRCCS Research Hospital, Milan, Italy; and.; Wellcome Trust-Medical Research Council Institute of Metabolic Science and.
Bourdin A; Département des Maladies Respiratoires and.; Cambridge National Institute for Health Research Biomedical Research Centre, University of Cambridge and Addenbrooke's Hospital, Cambridge, United Kingdom.
Pokaż więcej
Corporate Authors :
Oral Corticosteroids Tapering Delphi Expert Panel
Źródło :
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2021 Apr 01; Vol. 203 (7), pp. 871-881.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Administration Schedule*
Expert Testimony*
Adrenal Cortex Hormones/*administration & dosage
Adrenal Cortex Hormones/*standards
Adrenal Cortex Hormones/*therapeutic use
Asthma/*drug therapy
Administration, Oral ; Adult ; Consensus ; Delphi Technique ; Female ; Humans ; Male ; Middle Aged ; Practice Guidelines as Topic
Czasopismo naukowe
Tytuł :
Successful management of hemodialysis-dependent refractory myeloma with modified daratumumab, bortezomib and dexamethasone regimen.
Autorzy :
Mizuno S; Department of Nephrology, Japan Community Health Care Organization Sendai Hospital, 3-16-1, Tsutsumimachi, Aoba-Ku, Sendai, Miyagi, 981-8501, Japan. .
Kitayama C; Department of Nephrology, Japan Community Health Care Organization Sendai Hospital, 3-16-1, Tsutsumimachi, Aoba-Ku, Sendai, Miyagi, 981-8501, Japan.
Yamaguchi K; Department of Nephrology, Japan Community Health Care Organization Sendai Hospital, 3-16-1, Tsutsumimachi, Aoba-Ku, Sendai, Miyagi, 981-8501, Japan.
Sanada S; Department of Nephrology, Japan Community Health Care Organization Sendai Hospital, 3-16-1, Tsutsumimachi, Aoba-Ku, Sendai, Miyagi, 981-8501, Japan.
Sato T; Department of Nephrology, Japan Community Health Care Organization Sendai Hospital, 3-16-1, Tsutsumimachi, Aoba-Ku, Sendai, Miyagi, 981-8501, Japan.
Pokaż więcej
Źródło :
International journal of hematology [Int J Hematol] 2020 Dec; Vol. 112 (6), pp. 860-863. Date of Electronic Publication: 2020 Jul 24.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Drug Administration Schedule*
Renal Dialysis*
Acute Kidney Injury/*etiology
Acute Kidney Injury/*therapy
Antibodies, Monoclonal/*administration & dosage
Bortezomib/*administration & dosage
Dexamethasone/*administration & dosage
Multiple Myeloma/*complications
Aged ; Drug Therapy, Combination ; Female ; Humans ; Multiple Myeloma/immunology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
A comparative study between a single-dose and 24-hour multiple-dose antibiotic prophylaxis for elective hysterectomy.
Autorzy :
Akkour KM; Department of Obstetrics and Gynecology, College of Medicine, King Saud University and King Khalid University Hospital, Riyadh, Saudi Arabia. .
Arafah MA; Department of Pathology, College of Medicine, King Saud University, Riyadh, Saudi Arabia. .
Alhulwah MM; Department of Obstetrics and Gynecology, College of Medicine, King Saud University and King Khalid University Hospital, Riyadh, Saudi Arabia. .
Badaghish RS; Department of Obstetrics and Gynecology, College of Medicine, King Saud University and King Khalid University Hospital, Riyadh, Saudi Arabia. .
Alhalal HA; Department of Obstetrics and Gynecology, College of Medicine, King Saud University and King Khalid University Hospital, Riyadh, Saudi Arabia. .
Alayed NM; Department of Obstetrics and Gynecology, College of Medicine, King Saud University and King Khalid University Hospital, Riyadh, Saudi Arabia. .
Alqahtani SB; Infection Control Department, College of Medicine, King Saud University and King Khalid University Hospital, Riyadh, Saudi Arabia. .
Iqbal SSA; Faculty of Medicine, Alfarabi College of Medicine, Riyadh, Saudi Arabia. .
Pokaż więcej
Źródło :
Journal of infection in developing countries [J Infect Dev Ctries] 2020 Nov 30; Vol. 14 (11), pp. 1306-1313. Date of Electronic Publication: 2020 Nov 30.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Antibiotic Prophylaxis*
Drug Administration Schedule*
Anti-Bacterial Agents/*therapeutic use
Cefazolin/*therapeutic use
Hysterectomy/*adverse effects
Surgical Wound Infection/*prevention & control
Anti-Bacterial Agents/administration & dosage ; Cefazolin/administration & dosage ; Female ; Hospitals, University/statistics & numerical data ; Humans ; Middle Aged ; Quality of Life ; Retrospective Studies ; Risk Factors ; Surgical Wound Infection/microbiology
Czasopismo naukowe
Tytuł :
[The best time for a medication: how to sweeten the pill ?]
Autorzy :
Nachar C; Service de pharmacie, CHUV, 1011 Lausanne.
Perrottet N; Service de pharmacie, CHUV, 1011 Lausanne.
Garnier A; Service de médecine interne, CHUV, 1011 Lausanne.
Pokaż więcej
Transliterated Title :
Le bon moment pour un médicament: comment faire passer la pilule ?
Źródło :
Revue medicale suisse [Rev Med Suisse] 2020 Nov 25; Vol. 16 (716), pp. 2254-2258.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Administration Schedule*
Drug-Related Side Effects and Adverse Reactions/*prevention & control
Pharmaceutical Preparations/*administration & dosage
Humans
Czasopismo naukowe
Tytuł :
Use of Rifampin Compared with Isoniazid for the Treatment of Latent Tuberculosis Infection in Japan: A Bayesian Inference with Markov Chain Monte Carlo Method.
Autorzy :
Iwata K; Division of Infectious Diseases, Kobe University Hospital, Japan.
Morishita N; Department of Nursing, Hyogo Prefectural Kakogawa Medical Center, Japan.
Nishiwaki M; Department of Cardiovascular Surgery, Hyogo Prefectural Kakogawa Medical Center, Japan.
Miyakoshi C; Department of Research Support, Center for Clinical Research and Innovation, Kobe City Medical Center General Hospital, Japan.
Pokaż więcej
Źródło :
Internal medicine (Tokyo, Japan) [Intern Med] 2020 Nov 01; Vol. 59 (21), pp. 2687-2691. Date of Electronic Publication: 2020 Jul 14.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Drug Administration Schedule*
Drug-Related Side Effects and Adverse Reactions*
Antitubercular Agents/*therapeutic use
Isoniazid/*therapeutic use
Latent Tuberculosis/*drug therapy
Rifampin/*therapeutic use
Adult ; Aged ; Aged, 80 and over ; Bayes Theorem ; Female ; Humans ; Japan/epidemiology ; Latent Tuberculosis/epidemiology ; Male ; Markov Chains ; Middle Aged ; Monte Carlo Method
Czasopismo naukowe
Tytuł :
Identifying Risk Areas of Medication Administration Process for Developing an Interactive Three-Dimensional Game Intervention.
Autorzy :
Härkänen M; Author Affiliations: Department of Nursing Science, University of Eastern Finland, Academy of Finland, Kuopio (Dr Härkänen); Department of Nursing Science, University of Eastern Finland, and The South Savo Social and Health Care Authority (Ms Luokkamäki), Mikkeli, Finland; Department of Hospital Pharmacy, Kuopio University Hospital (Dr Saano); Department of Nursing Science, University of Eastern Finland, Kuopio, and Metropolia University of Applied Sciences, Helsinki (Ms Saastamoinen); and Department of Nursing Science, University of Eastern Finland, and Kuopio University Hospital (Dr Vehviläinen-Julkunen), Finland.
Luokkamäki S
Saano S
Saastamoinen T
Vehviläinen-Julkunen K
Pokaż więcej
Źródło :
Computers, informatics, nursing : CIN [Comput Inform Nurs] 2020 Oct; Vol. 38 (10), pp. 524-533.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Drug Administration Schedule*
Pharmaceutical Preparations*
Risk Management*
Medication Errors/*prevention & control
Critical Care ; Focus Groups ; Humans ; Workload/psychology
Czasopismo naukowe
Tytuł :
Safety and Efficacy of Intermittent Bolus and Continuous Infusion Neostigmine for Acute Colonic Pseudo-Obstruction.
Autorzy :
Smedley LW; Department of Pharmacotherapy and Pharmacy Services, University Health System, San Antonio, TX, USA.; School of Medicine, Pharmacotherapy Research and Education Center, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.; Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin, TX, USA.
Foster DB; Department of Pharmacotherapy and Pharmacy Services, University Health System, San Antonio, TX, USA.; School of Medicine, Pharmacotherapy Research and Education Center, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.; Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin, TX, USA.
Barthol CA; Department of Pharmacotherapy and Pharmacy Services, University Health System, San Antonio, TX, USA.; School of Medicine, Pharmacotherapy Research and Education Center, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.; Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin, TX, USA.
Hall R; Department of Pharmacotherapy and Pharmacy Services, University Health System, San Antonio, TX, USA.; School of Medicine, Pharmacotherapy Research and Education Center, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.; Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin, TX, USA.
Gutierrez GC; Department of Pharmacotherapy and Pharmacy Services, University Health System, San Antonio, TX, USA.; School of Medicine, Pharmacotherapy Research and Education Center, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.; Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin, TX, USA.
Pokaż więcej
Źródło :
Journal of intensive care medicine [J Intensive Care Med] 2020 Oct; Vol. 35 (10), pp. 1039-1043. Date of Electronic Publication: 2018 Oct 29.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Drug Administration Schedule*
Infusions, Parenteral*
Cholinesterase Inhibitors/*administration & dosage
Colonic Pseudo-Obstruction/*drug therapy
Neostigmine/*administration & dosage
Acute Disease ; Adult ; Aged ; Bradycardia/chemically induced ; Bradycardia/epidemiology ; Colonic Pseudo-Obstruction/physiopathology ; Defecation/drug effects ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Organ Dysfunction Scores ; Retrospective Studies ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Doses of primaquine administered to children with Plasmodium vivax according to an age-based dose regimen.
Autorzy :
Vieira MVDF; Pharmacy Faculty, Para Federal University , Belem, Brazil.
Matos Lopes TR; Pharmacy Faculty, Para Federal University , Belem, Brazil.
Mello AGNC; Pharmacy Faculty, Para Federal University , Belem, Brazil.
de Sena LWP; Pharmacy Faculty, Para Federal University , Belem, Brazil.
Commons RJ; Global Health Division, Menzies School of Health Research and Charles Darwin University , Darwin, Australia.; WorldWide Antimalarial Resistance Network , Oxford, UK.
Vieira JLF; Pharmacy Faculty, Para Federal University , Belem, Brazil.
Pokaż więcej
Źródło :
Pathogens and global health [Pathog Glob Health] 2020 Oct; Vol. 114 (7), pp. 388-392. Date of Electronic Publication: 2020 Jul 24.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Administration Schedule*
Malaria, Vivax*/drug therapy
Antimalarials/*administration & dosage
Primaquine/*administration & dosage
Adolescent ; Antimalarials/therapeutic use ; Child ; Child, Preschool ; Humans ; Infant ; Plasmodium vivax ; Primaquine/therapeutic use
Czasopismo naukowe
Tytuł :
A first-in-class, first-in-human, phase I trial of CIGB-552, a synthetic peptide targeting COMMD1 to inhibit the oncogenic activity of NF-κB in patients with advanced solid tumors.
Autorzy :
Vallespi MG; Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba.
Mestre B; National Institute of Oncology and Radiobiology (INOR), Havana, Cuba.
Marrero MA; National Coordinating Center for Clinical Trials (CENCEC), Havana, Cuba.
Uranga R; National Coordinating Center for Clinical Trials (CENCEC), Havana, Cuba.
Rey D; National Coordinating Center for Clinical Trials (CENCEC), Havana, Cuba.
Lugiollo M; National Institute of Oncology and Radiobiology (INOR), Havana, Cuba.
Betancourt M; National Institute of Oncology and Radiobiology (INOR), Havana, Cuba.
Silva K; National Institute of Oncology and Radiobiology (INOR), Havana, Cuba.
Corrales D; National Institute of Oncology and Radiobiology (INOR), Havana, Cuba.
Lamadrid Y; National Institute of Oncology and Radiobiology (INOR), Havana, Cuba.
Rodriguez Y; National Institute of Oncology and Radiobiology (INOR), Havana, Cuba.
Maceo A; National Coordinating Center for Clinical Trials (CENCEC), Havana, Cuba.
Chaviano PP; National Coordinating Center for Clinical Trials (CENCEC), Havana, Cuba.
Lemos G; Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba.
Cabrales A; Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba.
Freyre FM; Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba.
Santana H; Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba.
Garay HE; Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba.
Oliva B; Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba.
Fernandez JR; Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Sep 15; Vol. 149 (6), pp. 1313-1321. Date of Electronic Publication: 2021 May 27.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Agents/*administration & dosage
Cell-Penetrating Peptides/*administration & dosage
NF-kappa B/*drug effects
Neoplasms/*drug therapy
Adaptor Proteins, Signal Transducing/metabolism ; Adult ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/pharmacokinetics ; CD4-Positive T-Lymphocytes/drug effects ; CD8-Positive T-Lymphocytes/drug effects ; Cell-Penetrating Peptides/adverse effects ; Cell-Penetrating Peptides/pharmacokinetics ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Female ; Humans ; Injections, Subcutaneous ; Male ; Maximum Tolerated Dose ; Middle Aged ; Neoplasm Staging ; Neoplasms/metabolism ; Neoplasms/pathology ; Research Design ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Trastuzumab in combination with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the Arbeitsgemeinschaft Internistische Onkologie Gastric Cancer Study Group.
Autorzy :
Hofheinz RD; Interdisziplinäres Tumorzentrum, Universitätsmedizin Mannheim, Universität Heidelberg, Mannheim, Germany.
Hegewisch-Becker S; Hämatologisch-Onkologische Praxis Eppendorf, Hamburg, Germany.
Kunzmann V; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.
Thuss-Patience P; Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie, Charité, Universitätsmedizin Berlin, Berlin, Germany.
Fuchs M; Klinikum Bogenhausen, Klinik für Gastroenterologie, Hepatologie, Gastroenterologische Onkologie München, München, Germany.
Homann N; Medizinische Klinik II Wolfsburg, Wolfsburg, Germany.
Graeven U; Klinik für Hämatologie, Onkologie und Gastroenterologie, Kliniken Mariahilf, Mönchengladbach, Germany.
Schulte N; Interdisziplinäres Tumorzentrum, Universitätsmedizin Mannheim, Universität Heidelberg, Mannheim, Germany.
Merx K; Interdisziplinäres Tumorzentrum, Universitätsmedizin Mannheim, Universität Heidelberg, Mannheim, Germany.
Pohl M; Medizinische Universitätsklinik Bochum, Knappschaftskrankenhaus, Bochum, Germany.
Held S; ClinAssess GmbH, Leverkusen, Germany.
Keller R; AIO Studien gGmbH, Berlin, Germany.
Tannapfel A; Institut für Pathologie der Ruhr-Universität Bochum, Bochum, Germany.
Al-Batran SE; Institute of Clinical Cancer Research (IKF) at Krankenhaus Nordwest, UCT-University Cancer Center, Frankfurt am Main, Germany.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Sep 15; Vol. 149 (6), pp. 1322-1331. Date of Electronic Publication: 2021 May 29.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Adenocarcinoma/*drug therapy
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Esophageal Neoplasms/*drug therapy
Esophagogastric Junction/*pathology
Receptor, ErbB-2/*metabolism
Stomach Neoplasms/*drug therapy
Adenocarcinoma/metabolism ; Adenocarcinoma/pathology ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Docetaxel/administration & dosage ; Docetaxel/therapeutic use ; Drug Administration Schedule ; Esophageal Neoplasms/metabolism ; Esophageal Neoplasms/pathology ; Female ; Fluorouracil/administration & dosage ; Fluorouracil/therapeutic use ; Humans ; Leucovorin/administration & dosage ; Leucovorin/therapeutic use ; Male ; Middle Aged ; Neoplasm Staging ; Oxaliplatin/administration & dosage ; Oxaliplatin/therapeutic use ; Perioperative Period ; Stomach Neoplasms/metabolism ; Stomach Neoplasms/pathology ; Survival Analysis ; Trastuzumab/administration & dosage ; Trastuzumab/therapeutic use ; Treatment Outcome
SCR Disease Name :
Adenocarcinoma Of Esophagus
Czasopismo naukowe
Tytuł :
Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal Disease.
Autorzy :
Chuang WL; Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Hu TH; Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan.
Buggisch P; Ifi-Institut für Interdisziplinäre Medizin, Liver-Centre Hamburg, Hamburg, Germany.
Moreno C; CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
Su WW; Changhua Christian Hospital, Changhua City, Taiwan.
Biancone L; Università Degli Studi di Torino, Turin, Italy.
Camargo M; Gilead Sciences, Foster City, California, USA.
Hyland R; Gilead Sciences, Foster City, California, USA.
Lu S; Gilead Sciences, Foster City, California, USA.
Kirby BJ; Gilead Sciences, Foster City, California, USA.
Dvory-Sobol H; Gilead Sciences, Foster City, California, USA.
Osinusi A; Gilead Sciences, Foster City, California, USA.
Gaggar A; Gilead Sciences, Foster City, California, USA.
Peng CY; China Medical University Hospital, Taichung City, Taiwan.
Liu CH; National Taiwan University Hospital, Taipei City, Taiwan.
Sise ME; Massachusetts General Hospital, Boston, Massachusetts, USA.
Mangia A; Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy.
Pokaż więcej
Źródło :
The American journal of gastroenterology [Am J Gastroenterol] 2021 Sep 01; Vol. 116 (9), pp. 1924-1928.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiviral Agents/*therapeutic use
Benzimidazoles/*therapeutic use
Fluorenes/*therapeutic use
Hepatitis C/*drug therapy
Kidney Failure, Chronic/*therapy
Sofosbuvir/*therapeutic use
Adult ; Aged ; Aged, 80 and over ; Antiviral Agents/administration & dosage ; Benzimidazoles/administration & dosage ; Drug Administration Schedule ; Female ; Fluorenes/administration & dosage ; Hepatitis C/complications ; Humans ; Kidney Failure, Chronic/complications ; Male ; Middle Aged ; Sofosbuvir/administration & dosage ; Sustained Virologic Response ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial.
Autorzy :
Klok FA; Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University, Mainz, Germany; Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, Netherlands.
Toenges G; Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
Mavromanoli AC; Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
Barco S; Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University, Mainz, Germany; Clinic of Angiology, University Hospital Zurich, Zurich, Switzerland.
Ageno W; Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Bouvaist H; Department of Cardiology, Pôle Thorax et Vaisseaux, CHU Grenoble Alpes, La Tronche, France.
Brodmann M; Department of Angiology, Medical University Graz, Graz, Austria.
Cuccia C; Cardiovascular Department, Fondazione Poliambulanza, Istituto Ospedaliero, Brescia, Italy.
Couturaud F; Département de Médecine Interne et Pneumologie, Centre Hospitalo-Universitaire de Brest, and EA3878, FCRIN INNOVTE, Brest University, Brest, France.
Dellas C; Clinic of Paediatric Cardiology and Intensive Care, GUCH Center, University Medical Center Goettingen, Goettingen, Germany.
Dimopoulos K; Royal Brompton Hospital, and National Heart and Lung Institute, Imperial College London, London, UK.
Duerschmied D; Department of Cardiology and Angiology I, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Empen K; Department of Internal Medicine, Städtisches Klinikum Dessau, Dessau-Roßlau, Germany.
Faggiano P; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Institute of Cardiology, ASST Spedali Civili di Brescia, Brescia, Italy.
Ferrari E; Service de Cardiologie, Hôpital Pasteur, Centre Hospitalier Universitaire de Nice, Nice, France.
Galiè N; DIMES, University of Bologna and IRCCS, S Orsola University Hospital, Bologna, Italy.
Galvani M; Division of Cardiology, Department of Cardiovascular Diseases, AUSL Romagna, Ospedale Morgagni-Pierantoni, Forli, Italy; Cardiovascular Research Unit, Fondazione Cardiologica Myriam Zito Sacco, Forli, Italy.
Ghuysen A; Emergency Care, University Hospital Centre Liège, Liège, Belgium.
Giannakoulas G; Cardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Huisman MV; Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, Netherlands.
Jiménez D; Department of Respiratory Diseases, Ramon y Cajal Hospital, Universidad de Alcalá, CIBER Enfermedades Respiratorias (CIBERES), Madrid, Spain.
Kozak M; Department of Vascular Diseases, University Medical Center, Ljubljana, Slovenia.
Lang IM; Department of Cardiology, Medical University of Vienna, Vienna, Austria.
Lankeit M; Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University, Mainz, Germany; Clinic of Cardiology and Pneumology, University Medical Center Goettingen, Goettingen, Germany; Department of Internal Medicine and Cardiology, Charité-University Medicine Berlin, Germany.
Meneveau N; Department of Cardiology, University Hospital Jean Minjoz, Besançon, France; EA3920, University of Burgundy Franche-Comté, Besançon, France.
Münzel T; Department of Cardiology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
Palazzini M; DIMES, University of Bologna and IRCCS, S Orsola University Hospital, Bologna, Italy.
Petris AO; Grigore T Popa University of Medicine and Pharmacy Iasi, Cardiology Clinic, St Spiridon County Clinical Emergency Hospital, Iasi, Romania.
Piovaccari G; Department of Cardiovascular Diseases, Infermi Hospital, AUSL Romagna, Rimini, Italy.
Salvi A; Internal and Subintensive Medicine Department, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Ancona, Italy.
Schellong S; Department of Internal Medicine 2, Municipal Hospital Dresden, Dresden, Germany.
Schmidt KH; Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University, Mainz, Germany; Department of Cardiology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
Verschuren F; Emergency Department, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
Schmidtmann I; Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
Meyer G; Pulmonology and Intensive Care Service, Georges Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris, Paris Descartes University, INSERM UMR S 970, and INNOVTE, Paris, France.
Konstantinides SV; Department of Cardiology, Democritus University of Thrace, Alexandroupolis, Greece; Center for Thrombosis and Hemostasis, University Medical Center Mainz, Mainz, Germany. Electronic address: .
Pokaż więcej
Corporate Authors :
PEITHO-2 investigators
Źródło :
The Lancet. Haematology [Lancet Haematol] 2021 Sep; Vol. 8 (9), pp. e627-e636. Date of Electronic Publication: 2021 Aug 04.
Typ publikacji :
Clinical Trial, Phase IV; Journal Article; Multicenter Study
MeSH Terms :
Anticoagulants/*therapeutic use
Dabigatran/*therapeutic use
Pulmonary Embolism/*drug therapy
Administration, Oral ; Aged ; Aged, 80 and over ; Anticoagulants/adverse effects ; Dabigatran/adverse effects ; Drug Administration Schedule ; Female ; Follow-Up Studies ; Hemorrhage/etiology ; Heparin/therapeutic use ; Humans ; Male ; Middle Aged ; Pulmonary Embolism/complications ; Risk Factors ; Treatment Outcome ; Venous Thromboembolism/complications
Czasopismo naukowe
Tytuł :
An integrative review of method types used in the study of medication error during anaesthesia: implications for estimating incidence.
Autorzy :
Bratch R; Pharmacy Department, Royal Wolverhampton NHS Trust, Wolverhampton, UK.
Pandit JJ; Nuffield Department of Anaesthetics, Oxford University Hospitals, Oxford, UK. Electronic address: .
Pokaż więcej
Źródło :
British journal of anaesthesia [Br J Anaesth] 2021 Sep; Vol. 127 (3), pp. 458-469. Date of Electronic Publication: 2021 Jul 06.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Epidemiologic Research Design*
Medication Errors*
Anesthesia/*adverse effects
Anesthetics/*adverse effects
Anesthetics/administration & dosage ; Drug Administration Schedule ; Humans ; Incidence ; Patient Safety ; Risk Assessment ; Risk Factors ; Root Cause Analysis
Czasopismo naukowe
Tytuł :
Ceftriaxone and methicillin-susceptible staphylococcus aureus : a perspective from pharmacokinetics/pharmacodynamics studies.
Autorzy :
Telles JP; Department of Infectious Diseases, AC Camargo Cancer Center, São Paulo, SP, Brazil.; Department of Infectious Diseases, Hospital Universitário Evangélico Mackenzie, Curitiba, PR, Brazil.
Leme RCP; Department of Infectious Diseases, Hospital Unimed Volta Redonda, Volta Redonda, RJ, Brazil.
Campos ML; Federal University of Mato Grosso, Health Sciences Institute, Sinop, Mato Grosso, Brazil.
Ito C; Division of Microbiology, Universidade Estadual De Ponta Grossa, Ponta Grossa, PR, Brazil.; Laboratory of Emerging Infectious Diseases, Pontifícia Universidade Católica Do Paraná, Curitiba, PR, Brazil.
Bail L; Laboratory of Emerging Infectious Diseases, Pontifícia Universidade Católica Do Paraná, Curitiba, PR, Brazil.
Nogueira KDS; Hospital De Clínicas, Universidade Federal Do Paraná, Curitiba, PR, Brazil.; Basic Pathology Department, Universidade Federal Do Paraná, Curitiba, PR, Brazil.
Tuon FF; Department of Infectious Diseases, Hospital Universitário Evangélico Mackenzie, Curitiba, PR, Brazil.; Laboratory of Emerging Infectious Diseases, Pontifícia Universidade Católica Do Paraná, Curitiba, PR, Brazil.
Pokaż więcej
Źródło :
Expert opinion on drug metabolism & toxicology [Expert Opin Drug Metab Toxicol] 2021 Sep; Vol. 17 (9), pp. 1039-1048. Date of Electronic Publication: 2021 Aug 18.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Anti-Bacterial Agents/*administration & dosage
Ceftriaxone/*administration & dosage
Staphylococcal Infections/*drug therapy
Staphylococcus aureus/*drug effects
Anti-Bacterial Agents/pharmacokinetics ; Anti-Bacterial Agents/pharmacology ; Ceftriaxone/pharmacokinetics ; Ceftriaxone/pharmacology ; Drug Administration Schedule ; Drug Resistance, Bacterial ; Humans ; Methicillin/pharmacology ; Microbial Sensitivity Tests ; Staphylococcal Infections/microbiology ; Staphylococcus aureus/isolation & purification
Czasopismo naukowe
Tytuł :
Dramatic Response to Convalescent Hyperimmune Plasma in Association With an Extended Course of Remdesivir in 4 B Cell-Depleted Non-Hodgkin Lymphoma Patients With SARS-Cov-2 Pneumonia After Rituximab Therapy.
Autorzy :
Furlan A; Hematology Unit, Azienda ULSS2 Marca Trevigiana, Italy. Electronic address: .
Forner G; Infectious Disease Unit, Azienda ULSS2 Marca Trevigiana, Italy.
Cipriani L; Infectious Disease Unit, Azienda ULSS2 Marca Trevigiana, Italy.
Vian E; Microbiology Unit, Azienda ULSS2 Marca Trevigiana, Italy.
Rigoli R; Microbiology Unit, Azienda ULSS2 Marca Trevigiana, Italy.
Gherlinzoni F; Hematology Unit, Azienda ULSS2 Marca Trevigiana, Italy.
Scotton P; Infectious Disease Unit, Azienda ULSS2 Marca Trevigiana, Italy.
Pokaż więcej
Źródło :
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2021 Sep; Vol. 21 (9), pp. e731-e735. Date of Electronic Publication: 2021 May 21.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Adenosine Monophosphate/*analogs & derivatives
Alanine/*analogs & derivatives
COVID-19/*therapy
Lymphoma, Non-Hodgkin/*therapy
Rituximab/*therapeutic use
Adenosine Monophosphate/administration & dosage ; Alanine/administration & dosage ; B-Lymphocytes/pathology ; COVID-19/complications ; COVID-19/drug therapy ; Combined Modality Therapy ; Drug Administration Schedule ; Humans ; Immunization, Passive/methods ; Immunocompromised Host ; Immunosuppressive Agents/adverse effects ; Immunosuppressive Agents/therapeutic use ; Italy ; Lymphoma, Non-Hodgkin/complications ; Lymphoma, Non-Hodgkin/pathology ; Lymphopenia/etiology ; Lymphopenia/pathology ; Lymphopenia/therapy ; Male ; Middle Aged ; Pneumonia, Viral/complications ; Pneumonia, Viral/therapy ; Rituximab/adverse effects ; SARS-CoV-2/physiology ; Treatment Outcome
SCR Protocol :
COVID-19 drug treatment; COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
Patient-centric decision framework for treatment alterations in patients with Chemotherapy-induced Peripheral Neuropathy (CIPN).
Autorzy :
Hertz DL; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI 48109-1065, United States. Electronic address: .
Childs DS; Department of Oncology, Mayo Clinic, Rochester, MN 55905, United States. Electronic address: .
Park SB; Brain and Mind Centre, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia. Electronic address: .
Faithfull S; School of Health Sciences, University of Surrey, Guildford, Surrey, United Kingdom. Electronic address: .
Ke Y; Department of Pharmacy, National University of Singapore, Singapore. Electronic address: .
Ali NT; Department of Pharmacology, Faculty of Pharmacy, University of Khartoum, Khartoum, Sudan. Electronic address: .
McGlown SM; A Survivor's Lens, Swansea, IL, United States. Electronic address: .
Chan A; Department of Clinical Pharmacy Practice, University of California Irvine School of Pharmacy & Pharmaceutical Sciences, Irvine 92697-3958, United States. Electronic address: .
Grech LB; Medicine Monash Health, School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Australia. Electronic address: .
Loprinzi CL; Department of Oncology, Mayo Clinic, Rochester, MN 55905, United States. Electronic address: .
Ruddy KJ; Department of Oncology, Mayo Clinic, Rochester, MN 55905, United States. Electronic address: .
Lustberg M; Department of Internal Medicine, Division of Medical Oncology, The Ohio State University, Columbus, OH, USA. Electronic address: .
Pokaż więcej
Źródło :
Cancer treatment reviews [Cancer Treat Rev] 2021 Sep; Vol. 99, pp. 102241. Date of Electronic Publication: 2021 Jun 09.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antineoplastic Agents/*adverse effects
Neoplasms/*drug therapy
Peripheral Nervous System Diseases/*chemically induced
Peripheral Nervous System Diseases/*therapy
Antineoplastic Agents/administration & dosage ; Drug Administration Schedule ; Humans ; Patient-Centered Care ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł :
The Duration of Antibiotics Prophylaxis at the Time of Catheter Removal after Radical Prostatectomy: Clinically Integrated, Cluster, Randomized Trial.
Autorzy :
Ehdaie B; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Jibara G; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York.
Sjoberg DD; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Laudone V; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York.
Eastham J; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York.
Touijer K; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York.
Scardino P; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York.
Donahue T; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York.
Goh A; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York.
Vickers A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Sep; Vol. 206 (3), pp. 662-668. Date of Electronic Publication: 2021 Apr 27.
Typ publikacji :
Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
MeSH Terms :
Antibiotic Prophylaxis/*methods
Catheter-Related Infections/*epidemiology
Postoperative Complications/*epidemiology
Prostatectomy/*adverse effects
Urinary Tract Infections/*epidemiology
Aged ; Anti-Bacterial Agents/administration & dosage ; Antibiotic Prophylaxis/statistics & numerical data ; Catheter-Related Infections/microbiology ; Catheter-Related Infections/prevention & control ; Catheters/adverse effects ; Ciprofloxacin/administration & dosage ; Cross-Over Studies ; Device Removal/adverse effects ; Drug Administration Schedule ; Humans ; Incidence ; Male ; Middle Aged ; Postoperative Complications/microbiology ; Postoperative Complications/prevention & control ; Prostate/surgery ; Prostatic Neoplasms/surgery ; Time Factors ; Treatment Outcome ; Urinary Catheterization/adverse effects ; Urinary Catheterization/instrumentation ; Urinary Tract Infections/microbiology ; Urinary Tract Infections/prevention & control
Czasopismo naukowe
Tytuł :
Preoperative opioid use: a modifiable risk factor for poor postoperative outcomes.
Autorzy :
Quinlan J; Nuffield Department of Anaesthetics, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Levy N; Department of Anaesthesia and Perioperative Medicine, West Suffolk NHS Foundation Trust, Bury St Edmunds, Suffolk, UK.
Lobo DN; Gastrointestinal Surgery, Nottingham Digestive Diseases Centre, National Institute for Health Research Nottingham Biomedical Research Centre, Nottingham University Hospitals and University of Nottingham, UK; MRC Versus Arthritis Centre for Musculoskeletal Ageing Research, School of Life Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, UK. Electronic address: .
Macintyre PE; Department of Anaesthesia, Pain Medicine and Hyperbaric Medicine, Royal Adelaide Hospital and University of Adelaide, Adelaide, SA, Australia.
Pokaż więcej
Źródło :
British journal of anaesthesia [Br J Anaesth] 2021 Sep; Vol. 127 (3), pp. 327-331. Date of Electronic Publication: 2021 Jun 02.
Typ publikacji :
Editorial
MeSH Terms :
Analgesics, Opioid/*adverse effects
Chronic Pain/*drug therapy
Postoperative Complications/*etiology
Surgical Procedures, Operative/*adverse effects
Analgesics, Opioid/administration & dosage ; Animals ; Chronic Pain/diagnosis ; Chronic Pain/immunology ; Drug Administration Schedule ; Humans ; Immunocompromised Host ; Neurosecretory Systems/drug effects ; Neurosecretory Systems/physiopathology ; Postoperative Complications/immunology ; Postoperative Complications/physiopathology ; Postoperative Complications/therapy ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies